AWM
IRWD icon

Ariadne Wealth Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Ariadne Wealth Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.3K Sell
11,957
-607
-5% -$2.34K 0.02% 250
2026
Q1 		$44.1K Buy
12,564
+340
+3% +$1.39K 0.02% 245
2025
Q4 		$56.4K Sell
12,224
-17
-0.1% -$44 0.02% 257
2025
Q3 		$41.3K Sell
12,241
-648
-5% -$671 0.02% 243
2025
Q2 		$14K Buy
+12,889
New +$10.1K 0.01% 229

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Ariadne Wealth Management's IRWD Position: Q2 2026 in Review

Ariadne Wealth Management reduced its Ironwood Pharmaceuticals (IRWD) stake by 4.8% in Q2 2026, selling an estimated $2.34K and leaving 11,957 shares worth $50.3K. The position accounts for 0.02% of the portfolio, ranked #250.

Ariadne Wealth Management first reported a position in IRWD in Q2 2025 and has held it in 5 quarters since. The position peaked at $56.4K in Q4 2025. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Ariadne Wealth Management held 11,957 shares of Ironwood Pharmaceuticals worth $50.3K as of Q2 2026.
  • Ariadne Wealth Management sold 607 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $2.34K.
  • Ironwood Pharmaceuticals made up 0.02% of Ariadne Wealth Management's portfolio in Q2 2026, its #250 holding.
  • Ariadne Wealth Management first reported a position in Ironwood Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Ariadne Wealth Management's Ironwood Pharmaceuticals position peaked at $56.4K in Q4 2025.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Ariadne Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.